Sequenom stock leads downward biotech trend

Sequenom Inc. shares drop 20% Tuesday, leading a general decline in the biotech sector, after the San Diego-based firm posted a larger-than-expected loss for the fourth quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.